PCCA continues to set the bar for compounding innovation! Fresh off its debut at PCCA’s ThinkNext 2025 International Seminar, UniFlow™ — our optimized excipient base engineered specifically for T3 and T4 powder triturations — is ready to transform your workflow with superior flow, uniformity, stability and time savings validated in real pharmacy settings.

What You’ll Learn:

The science behind UniFlow — including why it outperforms traditional fillers and how its low‑moisture design enhances stability and moisture protection for sensitive APIs

Practical workflow gains, including approximately 50% faster powder trituration and efficiencies when using the mortar and pestle method

Specific UniFlow formulations you can implement right away, plus practical tips and studies

Calculation conversions to confidently transition patients from desiccated thyroid extract (DTE) to liothyronine sodium (T3) and levothyroxine sodium (T4)

Speakers

PCCA Vice President of Research & Development Daniel Banov, MS, RPh

PCCA Clinical Compounding Pharmacist Ranel Larsen, PharmD

PCCA Senior Director of Formulations Melissa Merrell Rhoads, PharmD

Don’t miss this unique opportunity to elevate precision, consistency and efficiency in your compounding practice.